Large uterine leiomyoma in a young patient
Main Article Content
Keywords
Leiomyoma, Uterine, Uterine Neoplasms, Uterine Myomectomy
Abstract
Background: great elements uterine leiomyomas are the most common tumors in the reproductive life affecting up to 30 % of the women in the United States. It’s a etiology remains uncertain; cryptogenic studies suggest that 40 to 50 % present chromosomic abnormalities. Clinical manifestations are: hypermenorrhea and abdominal pain. In the great element cases, patients suffered intestinal constipation and rectal tenesm. The treatment includes analogous of human chorionic gonadotrophin liberation hormone (GnRH), progesterone, surgical treatment, myomectomy and hysterectomy, uterine artery embolization, high frequency ultrasound, laser, cryotherapy and thermos ablation.
Clinical case: an 18 year-old female, menarquia at 12, periods 28/4, nubil. 6 months previous: intestinal constipation, tumor-like mass in hypogastrium, of about 8 cm in diameter, which increased gradually up to 18 cm, smooth, movile and irregular. The pelvic ultrasound showed a tumor of 140 mm dependent of uterus. Myomectomy was performed. The histopathologic report was a 19.9 cm uterine leiomyoma, weighing 949 g and with hyaline degeneration. The patient was asymptomatic and without relapse a year later.
Conclusions: myomectomy is the choice treatment for the large uterine myomatosis when the patient’s fertility is to be preserved.
References
Arslan AA, Gold LI, Khushbakhat M, Ting-Chung S, Belitskaya-Levy I, Moon-Shong T, Toniolo P. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod 2005;20(4); 852- 863.
Koutsilieris M. Pathophysiology of uterine leiomyomas. Biochem Cell Biol 1992;5:273-278.
Uimari O, Suomalainen-Konig S, Sakkinen N, Santala M, Nieminen P, Ryynanen M. Natural history of familial myomas. Eur J Obstet Gynecol Reprod Biol 2006;125(2):255-258.
Wallach Edward E, Vlahos Nikos F. Uterine myomas: an overview of development, clinical features, and management. Obstet Gynecol 2004; 104 (2);393-406.
Spies JB, Patel AA, Epstein NB, White AM. Recent advances in uterine fibroid embolization. Curr Opin Obstet Gynecol 2005;17:562-567.
Baakdah H, Tulandi T. Uterine fibroid embolization. Clin Obstet Gynecol 2005;48(2):361-368.
Tropeano G. The role of uterine artery embolization in the management of uterine fibroids. Curr Opin Obstet Gynecol 2005;17:329-332.
Sharp HT. Assessment of new technology in the treatment of idiopathic amenorrhagia and uterine leiomyomata. Obstet Gynecol 2006;108(4);990- 1003.
Fambrini M, Penna C, Pieralli A, Andersson KL, Zambelli V, Scarselli G, Marchionni M. Feasibility of myomectomy performed by minilaparotomy. Acta Obstet Gynecol Scand 2006;85(9):1109-1113.
Carminati R, Ragusa A, Giannice R, Pantano F. Anterior and posterior vaginal myomectomy: a new surgical technique. Med Gen Med 2006;8(1);42.